Skip to main content
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
28.53
-0.52 (-1.77%)
Apr 29, 2026, 10:16 AM EDT - Market open

IDEAYA Biosciences Revenue

In the year 2025, IDEAYA Biosciences had annual revenue of $218.71M with 3,024.43% growth. IDEAYA Biosciences had revenue of $10.88M in the quarter ending December 31, 2025, with 55.37% growth.

Revenue (ttm)
$218.71M
Revenue Growth
+3,024.43%
P/S Ratio
11.66
Revenue / Employee
$1,508,345
Employees
145
Market Cap
2.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025218.71M211.71M3,024.43%
Dec 31, 20247.00M-16.39M-70.07%
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ADMA Biologics 510.17M
Tarsus Pharmaceuticals 451.36M
Soleno Therapeutics 190.41M
Beam Therapeutics 139.74M
Immunome 6.94M
Celldex Therapeutics 1.55M
Revenue Rankings

IDYA News

More News